Corey Davis Recent News
Why Kite Pharma Investors Should Expect Lymphoma Treatment FDA Approval In 2017
Good News And Bad News For Ohr Pharmaceuticals
H.C. Wainwright Is Bullish On Cara Therapeutics Shares
Lipocine Showered With Good News Recently
HC Wainwright's New Buy Rating On Lipocine Suggests 500% Upside
vTv Therapeutics Shares Initiated With Buy Rating, $13 Target
'Grass Is Greener' For Zynerba Pharma: Buy The Stock, Says Canaccord
Canaccord Hot And Cold On Deals By Teva Pharmaceutical, ImmunoGen
UPDATE: Jefferies Downgrades Warner Chilcott on Pending ACT Acquisition
UPDATE: Jefferies Raises PT on AcelRx Pharmaceuticals Following Model Assumption Updates
UPDATE: Jefferies Raises PT on Forest Laboratories Following New Board Member Announcement
UPDATE: Jefferies Raises PT on Endo Health Following DeSilva Public Appearance
UPDATE: Jefferies Raises PT on Salix Pharmaceuticals on Street Estimates Upside
UPDATE: Jefferies Reiterates Hold Rating, Raises PT on Actavis on WCRX Acquisition Announcement
Jefferies & Company Likes Endo Pharmaceuticals (ENDP) Acquisition Plans